CRSP icon

CRISPR Therapeutics

181 hedge funds and large institutions have $1.29B invested in CRISPR Therapeutics in 2019 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+11
Holders Change %
+6.47%
% of All Funds
3.94%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.15%
New
42
Increased
44
Reduced
36
Closed
29
Calls
$30.6M
Puts
$26.4M
Net Calls
+$4.21M
Net Calls Change
+$11.8M
Name Holding Trade Value Shares
Change
Shares
Change %
GSC
151
G&S Capital
Colorado
$12K
EWM
152
Executive Wealth Management
Michigan
$10K
FWM
153
Focused Wealth Management
New York
$9K
CCM
154
Cribstone Capital Management
Maine
$9K
WT
155
Whittier Trust
California
$9K
1IA
156
1834 Investment Advisors
Wisconsin
$9K
BCA
157
Berman Capital Advisors
Georgia
$9K +$9K +200 New
Carson Wealth (CWM LLC)
158
Carson Wealth (CWM LLC)
Nebraska
$8K
WAP
159
Wealthcare Advisory Partners
Pennsylvania
$7K
GWMIA
160
Global Wealth Management Investment Advisory
Florida
$7K
RWA
161
Ropes Wealth Advisors
Massachusetts
$6K
SIM
162
Sonora Investment Management
Arizona
$5K
YWP
163
YorkBridge Wealth Partners
New York
$5K
Fifth Third Bancorp
164
Fifth Third Bancorp
Ohio
$5K
MPWT
165
MassMutual Private Wealth & Trust
Connecticut
$4K
AA
166
AlphaMark Advisors
Kentucky
$4K
MF
167
Manchester Financial
California
$4K +$4K +75 New
RE
168
RBC Europe
United Kingdom
$3.01K +$3.01K +64 New
TCM
169
Tradewinds Capital Management
Washington
$3K -$923 -20 -24%
LF
170
Lee Financial
Texas
$3K
EWM
171
Elmwood Wealth Management
California
$3K
NFG
172
Next Financial Group
Texas
$3K +$3K +60 New
LC
173
Lindbrook Capital
California
$2K
SBL
174
Sargent Bickham Lagudis
Colorado
$2K
FRA
175
Front Row Advisors
California
$2K